← back to search

Alessandro Sette

University of California System · US
Area of research
Immunology · Molecular Biology · mRNA vaccine adjuvant
Research interest
Professor Center for Infectious Disease and Vaccine Research Center for Autoimmunity and Inflammation La Jolla Institute for Immunology
h-index
174
citations
122,538
works
1,441
NIH funding
$10.1M
primary concept
email

Recent publications

Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals.
2026cited by 2position: contributordoi
Symptomatic SARS-CoV-2 breakthrough infections broaden the repertoire of Spike-reactive CD4 T cells.
2026cited by 0position: contributordoi
Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.
2026cited by 0position: contributordoi
NetMHCIIphosPan: a machine learning tool for predicting HLA class II antigen presentation of phosphorylated peptides
2026cited by 0position: contributordoi
Curation at Scale with EPITOME: Extraction Pipeline for Immunological Texts and Open-Source Multimodal Enquiry
2026cited by 0position: contributordoi
Targets of influenza human T-cell response are mostly conserved in H5N1.
2025cited by 16position: contributordoi
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis
Nature 2025cited by 12position: lastdoi
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.
2025cited by 7position: contributordoi
PD-1 and CD73 on naive CD4<sup>+</sup> T cells synergistically limit responses to self.
2025cited by 6position: contributordoi
T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease
npj Parkinson s Disease 2025cited by 6position: lastdoi
Th1 polarization in Bordetella pertussis vaccine responses is maintained through a positive feedback loop.
2025cited by 5position: contributordoi
Loss of effector Treg signature in APOB-reactive CD4+ T cells in patients with coronary artery disease
Nature Cardiovascular Research 2025cited by 4position: middledoi
Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease
Nature Communications 2025cited by 4position: middledoi
Loss of effector T<sub>reg</sub> signature in APOB-reactive CD4<sup>+</sup> T cells in patients with coronary artery disease.
2025cited by 2position: contributordoi
Human CD4+ T cells recognize Mycobacterium tuberculosis-infected macrophages amid broader responses.
2025cited by 2position: contributordoi
Peptide MegaPools Approach to Evaluate the Dengue-Specific CD4 and CD8 T-Cell Response.
2025cited by 1position: contributordoi
Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4<sup>+</sup> T cells in chronic chikungunya disease.
2025cited by 1position: contributordoi
T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease
2025cited by 1position: contributordoi
Peptide Driven Identification of TCRs (PDI-TCR) reveals dynamics and phenotypes of CD4 T cells in tuberculosis
2025cited by 1position: contributordoi
Pediatric T cell and B cell responses to SARS-CoV-2 infection
JCI Insight 2025cited by 1position: contributordoi
New life into pertussis prevention.
2025cited by 0position: contributordoi
Cancer Epitope Prediction Tools & Analysis Pipelines in CEDAR
2025cited by 0position: contributordoi
Mpox-specific cellular and humoral immunity in mpox survivors living with HIV.
2025cited by 0position: contributordoi
Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to α-synuclein
2025cited by 0position: contributordoi
Supplementary Table S1 from Impaired SARS-CoV-2 Variant Neutralization and CD8<sup>+</sup> T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
2025cited by 0position: contributordoi
Supplementary Tables S2-S4 from Impaired SARS-CoV-2 Variant Neutralization and CD8<sup>+</sup> T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
2025cited by 0position: contributordoi
Supplementary Figures from Impaired SARS-CoV-2 Variant Neutralization and CD8<sup>+</sup> T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
2025cited by 0position: contributordoi
Inactivated Zoonotic Influenza A(H5N8) Vaccine Induces Humoral and Cell-mediated Immune Responses Against Highly Pathogenic Avian Influenza Clade 2.3.4.4b A(H5N1) Viruses
2025cited by 0position: contributordoi
Characterizing antibodies binding to the same epitope reveals limited contribution by heavy chain CDR3 sequences relative to other CDRs
2025cited by 0position: contributordoi
The Immune Epitope Database (IEDB): 2024 update
Nucleic Acids Research 2024cited by 170position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 116 papers (2019–2026)Bjoern Peters · La Jolla Institute for Immunology61 papers (2012–2024)John Sidney · La Jolla Institute for Immunology58 papers (2012–2025)Alba Grifoni · La Jolla Institute for Immunology49 papers (2018–2025)Daniela Weiskopf · La Jolla Institute for Immunology47 papers (2013–2025)Alba Grifoni · Vita-Salute San Raffaele University42 papers (2020–2026) · 39 papers (2012–2025)Daniela Weiskopf · Center for Global Health32 papers (2020–2025)Shane Crotty · La Jolla Institute for Immunology24 papers (2013–2024)April Frazier · La Jolla Alcohol Research22 papers (2017–2025)Jason Greenbaum · Moores Cancer Center22 papers (2012–2024)Bjoern Peters · Center for Infectious Disease and Vaccine Research17 papers (2019–2026)Jennifer M. Dan · University of California System16 papers (2016–2024)Cecilia S. Lindestam Arleham · University of Washington15 papers (2019–2026)Ricardo da Silva Antunes · University of California San Diego14 papers (2016–2024)David Sulzer · Columbia University Irving Medical Center13 papers (2017–2025)S. Mallal · Tennessee Department of Health13 papers (2012–2025)José Mateus · Pontificia Universidad Javeriana12 papers (2020–2022)Elizabeth J. Phillips · University of Manitoba12 papers (2012–2025)Pandurangan Vijayanand · La Jolla Institute for Immunology11 papers (2016–2021)